Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: Determinants and prognostic value

Canadian Respiratory Journal

Volumn 20, Issue 5, 2013, Pages

  Feliz Rodriguez, Darwin ^a   Zudaire, Santiago ^a   Carpio, Carlos ^a   Martínez, Elizabet ^a   Gómez Mendieta, Antonia ^a   Santiago, Ana ^a   Alvarez Sala, Rodolfo ^a,b   García Río, Francisco ^a,b,c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Exacerbation; Health status; Prognostic; Questionnaires; Recovery

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONVALESCENCE; COPD ASSESSMENT TEST; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE STAGE; HEALTH STATUS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MALE; OXYGEN THERAPY; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; SCORING SYSTEM; SPIROMETRY;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84885572286     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/398120     Document Type: Article

References (29)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
2. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180:506-12.
3. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: A cross-sectional study. Am J Respir Crit Care Med 2008;177:743-51. (Pubitemid 351490561)
4. Pauwels R, Calverley P, Buist AS, et al. COPD exacerbations: The importance of a standard definition. Respir Med 2004;98:99-107. (Pubitemid 38181126)
5. Hurst JR, Wedzicha JA. What is (and what is not) a COPD exacerbation: Thoughts from the new GOLD guidelines. Thorax 2007;62:198-99. (Pubitemid 46579796)
6. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007;131:696-704. (Pubitemid 46446859)
7. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency, lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52. (Pubitemid 35178607)
8. Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea, disease-specific quality of life following an acute COPD exacerbation. Chest 2002;121:688-96. (Pubitemid 34251429)
9. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations, mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31. (Pubitemid 41598207)
10. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy NK. Development, first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
11. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD Assessment Test (CAT) in a cross-sectional European study. Eur Respir J 2011;38:29-35.
12. Kelly JL, Bamsey O, Smith C, et al. Health status assessment in routine clinical practice: The chronic obstructive pulmonary disease assessment test score in outpatients. Respiration 2012;84:193-99.
13. Mackay AJ, Donaldson GC, Patel ARC, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012;185:1218-24.
14. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: The updated BODE index, the ADO index. Lancet 2009;374:704-11.
15. Miller MR, Hankinson J, Brusasco V, et al. Standardization of spirometry. Eur Respir J 2005;26:319-38.
16. Quanjer PH, Trammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes, forced ventilatory flows. Report Working Party Standardization of Lung Function Tests. European Community for Steel, Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;6:5s-40s.
17. Snijders T, Bosker R. Multilevel Analysis: An Introduction to Basic, Advanced Multilevel Modeling. London: Sage, 1999.
18. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-5. (Pubitemid 20045528)
19. Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J COPD 2011;6:289-96.
20. Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): Response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011;66:425-9.
21. Jones PW, Harding G, Wiklund I, Yu R, Kline Leidy N. The COPD Assessment Test™ (CAT) can detect changes in health status during recovery from acute exacerbations. Am J Respir Crit Care Med 2010;181:A5954.
22. Spencer S, Jones PW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003;58:589-93. (Pubitemid 36808129)
23. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health related quality of life, mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680-5. (Pubitemid 34971850)
24. Cotes JE, Chinn DJ, Reed JW. Body mass, fat percentage, and fat free mass as reference variables for lung function: Effects on terms for age, sex. Thorax 2001;56:839-44. (Pubitemid 32999830)
25. Miravitlles M, Naberan K, Cantoni J, Azpeitia A. Socioeconomic status, health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration 2011;82:402-8.
26. Kessler R, Stahl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: An observational, interview based study. Chest 2006;130:133-42. (Pubitemid 44116851)
27. Esteban C, Quintana JM, Moraza J, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med 2009;103:1201-8.
28. Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum, functional impairment in patients with acute exacerbations of COPD. Chest 1999;116:40-6. (Pubitemid 29340258)
29. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation, the frequency, character, severity of COPD exacerbations. Thorax 2002;57:759-64. (Pubitemid 34984972)